Grönqvist, Erik; Lundin, Douglas - Economics Institute for Research (SIR), … - 2006
companies
to conduct con�rmatory studies just to make sure the new drug is safe. In fact, about two-thirds of all new
molecular … entities approved in 2000 were supposed to undergo Phase IV studies for follow up on safety (Angell,
2004, p. 163).
2To … quality being low, p, is known from inconclusive Phase III studies upon
which registration is based. Based on this information …